TickerFactsScreenerDevelopers

Viking Therapeutics, Inc. (VKTX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2014: -$23.47M2015: -$12.00M2016: -$13.85M2017: -$19.07M2018: -$26.16M2019: -$32.69M2020: -$42.66M2021: -$55.68M2022: -$70.36M2023: -$100.83M2024: -$150.92M2025: -$393.34M-$393.34M
2014Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$393.34M-160.6%
2024-$150.92M-49.7%
2023-$100.83M-43.3%
2022-$70.36M-26.4%
2021-$55.68M-30.5%
2020-$42.66M-30.5%
2019-$32.69M-24.9%
2018-$26.16M-37.2%
2017-$19.07M-37.7%
2016-$13.85M-15.4%
2015-$12.00M+48.9%
2014-$23.47M—